Literature DB >> 11722066

Decade-long experience with surgical therapy of myasthenia gravis: early complications of 324 transsternal thymectomies.

J Kas1, D Kiss, V Simon, E Svastics, L Major, A Szobor.   

Abstract

BACKGROUND: We studied the incidences and evaluated the management of early postoperative complications after thymectomy for myasthenia gravis.
METHODS: During the period between 1987 and 1996, 324 thymectomies were performed through median sternotomy access under general anesthesia. Postoperative management was administered according to a standardized protocol of anticholinesterase medication, which was withdrawn for the 48 hours of obligatory postoperative mechanical ventilation. The mean age of patients was 34 years (range, 8 to 71 years).
RESULTS: One hundred forty-nine patients made an uneventful recovery; 104 patients had only minor complications, whereas 71 patients had major complications. The mortality rate was 0.6% (2 patients). The major surgical complications were recorded as sternal bleeding (1 patient) and sternal disruption (1 patient). The major general complications were recorded as tracheal stenosis (1 patient), pneumonia (3 patients), heart failure (1 patient), gastric hemorrhage (1 patient), and respiratory insufficiency (71 patients). Forty-six reintubations were performed on 40 patients and 19 tracheostomies (6%) were performed postoperatively.
CONCLUSIONS: The excessive incidence of respiratory insufficiency and airway-associated morbidity was potentially related, at least partially, to prolonged mechanical ventilation and withdrawal of anticholinesterase medication. Earlier weaning of patients with revision of 48-hour withdrawal of anticholinesterase medication is necessary.

Entities:  

Mesh:

Year:  2001        PMID: 11722066     DOI: 10.1016/s0003-4975(01)03080-6

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  18 in total

1.  Myasthenic crisis.

Authors:  Linda C Wendell; Joshua M Levine
Journal:  Neurohospitalist       Date:  2011-01

2.  Sugammadex in the management of myasthenic patients undergoing surgery: beyond expectations.

Authors:  Michele Carron; Alessandro De Cassai; Federico Linassi
Journal:  Ann Transl Med       Date:  2019-12

3.  Extended thymectomy in patients with myasthenia gravis with high thoracic epidural anesthesia alone.

Authors:  Yoshio Tsunezuka; Makoto Oda; Isao Matsumoto; Masaya Tamura; Go Watanabe
Journal:  World J Surg       Date:  2004-09-29       Impact factor: 3.352

Review 4.  Effectiveness of thymectomy in non-thymomatous myasthenia gravis: a systematic review.

Authors:  Yan Luo; Deng-Ji Pan; Fei-Fei Chen; Ming-Hui Zhu; Jing Wang; Min Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-12-06

5.  Effects of General-epidural Anaesthesia on Haemodynamics in Patients with Myasthenia Gravis.

Authors:  X-Z Liu; C-W Wei; H-Y Wang; Y-H Ge; J Chen; J Wang; Y Zhang
Journal:  West Indian Med J       Date:  2015-01-28       Impact factor: 0.171

6.  Anaesthetic considerations in paediatric myasthenia gravis.

Authors:  Oliver William Masters; Oliver N Bagshaw
Journal:  Autoimmune Dis       Date:  2011-09-25

7.  Late onset seroma post-thymectomy presenting as cardiac tamponade.

Authors:  Dilli Ram Poudel; Smith Giri; Ranjan Pathak; Mohamed Morsey; Shadwan Alsafwah
Journal:  J Community Hosp Intern Med Perspect       Date:  2015-06-15

Review 8.  Understanding the burden of refractory myasthenia gravis.

Authors:  Christiane Schneider-Gold; Tim Hagenacker; Nico Melzer; Tobias Ruck
Journal:  Ther Adv Neurol Disord       Date:  2019-03-01       Impact factor: 6.570

9.  The Effect of Immunonutrition on the Postoperative Complications in Thymoma with Myasthenia Gravis.

Authors:  Yanzhong Xin; Hongfei Cai; Lihui Wu; Youbin Cui
Journal:  Mediators Inflamm       Date:  2016-11-10       Impact factor: 4.711

10.  Influence of body mass index on postoperative complications after thymectomy in myasthenia gravis patients.

Authors:  Xu-Dong Liu; Ming-Rui Shao; Lei Sun; Lin Zhang; Xin-Shan Jia; Wen-Ya Li
Journal:  Oncotarget       Date:  2017-07-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.